🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Congratulations to Dr. Vanessa Merker Vanessa L. Merker, PhD for winning the inaugural REiNS Collaboration Award for Outstanding Service. This international group, co-founded by Pappas Center director Dr. Scott Plotkin, works to improve neurofibromatosis and schwannomatosis clinical trial design.

Neurotoxicity and management of primary and secondary CNS lymphoma after adoptive immunotherapy with CD19-directed CAR T-cells academic.oup.com/neuro-oncology…

Celebrating a new academic year together and our four faculty members who were promoted Harvard Medical School this summer. Congratulations to our new Associate Professors, Justin Jordan and Michael Parsons, and Assistant Professors, Albert Kim and Vanessa Merker!

Congrats to Dr. Jessica Lin and brain tumor team Dr. Nancy Wang, Dr. Helen Shih, and NP Peggy Leland for receiving the IASLC Cancer Care Team Award!

Exciting work by Dr. Deborah Forst and colleagues on psychological intervention for caregivers of patients with primary malignant brain tumors: bmjopen.bmj.com/content/13/9/e…

BRAF–MEK Inhibition in Newly Diagnosed Papillary Craniopharyngiomas | NEJM nejm.org/doi/full/10.10…

About a year ago and more relevant than ever!

Truly an honor to present this work at CNS on behalf of the highly collaborative effort spanning a decade. Changing standard of care in tumor diagnostics through teamwork. MassGeneralNeuroscience MGH Pathology MGHNeuroOncology Bob Carter MD PhD Brian Nahed MD MSC FCNS FAANS FACS

Register for the annual Miles for Mary 5k Run and Walk on Saturday, October 14th, to support brain tumor research at MGH! milesformary.com

Join us October 27th at the JBL Symposium to learn from leaders in neuroscience and radiation oncology including: Helen Shih from Mass General Cancer Center Shawn Hervey-Jumper from UCSF Health Scott Floyd from Duke Radiation Oncology Kristin Redmond from Johns Hopkins Medicine Info: hsph.harvard.edu/jbl-center/jbl…

The website for our MGHNeuroOncology-based NF research group is live! Check out our team, see a sample of our projects and publications, watch our recent educational talks and join the list to be invited to future #neurofibromatosis & #schwannomatosis events. massgeneral.org/neurology/rese…

.Vanessa L. Merker, PhD is a researcher striving to improve care for patients battling rare diseases like #neurofibromatosis type 1 and schwannomatosis. Learn more about her work 🧠. #RareDiseases #PatientCare mgriblog.org/2024/02/29/rar…

Great work from Anthony Anthony Wang and colleagues on this study! Allegra Petti MGH Neurosurgery MGHNeuroOncology Mass General Cancer Center Harvard Immunology WashU Med Taylor Family Department of Neurosurgery @WUSTLlImmuno

Calling all #Neurofibromatosis and #Schwannomatosis families in the Boston area! Register for our annual symposium on Saturday, April 6th! NF Northeast Children's Tumor Fdn MGHNeuroOncology Boston Children's eventbrite.com/e/neurofibroma…

Clinical trial results from show "dramatic & rapid" regression of glioblastoma after next generation CAR T therapy at the Mass General Cancer Center with Dr Marcela Maus, MD, director of the Cellular Immunotherapy Program. Learn more: spklr.io/6017Wf5Z NEJM

Congrats to Dr. Bryan Choi, Dr. Elizabeth Gerstner, and the rest of the team on their recent publication in NEJM! massgeneral.org/news/press-rel… MGH Neurosurgery Brain Tumor News Mass General Cancer Center @MGH_RI

Our prospective study now in @BloodJournal! CSF genotyping to facilitate diagnosis of #braintumors. This cell free MYD88 L265P assay in CSF w 2d turnaround now available MGH Pathology. MassGeneralNeuroscience Mass General Cancer Center MGHNeuroOncology MGH Neurosurgery #liquidbiopsy ashpublications.org/blood/article/…

The recording of our webinar on Avastin Treatment for NF2 with experts Dr. Scott Plotkin and Dr. Gareth Evans is now available on our website! Watch now to learn about Avastin treatment, ongoing trials, progesterone updates, and more. Check it out here: buff.ly/3yqfsj1

Brigatinib is a treatment option for progressive tumors in NF2-related schwannomatosis. Results from this innovative multi-center, adaptive, platform/basket trial, led by Pappas Center director Dr. Scott Plotkin, are out now in NEJM.

In a new NEJM study, researchers from Mass General Cancer Center and colleagues found that an approved drug may be repurposed to treat #tumors resulting from NF2-related schwannomatosis. Read more: massgeneral.org/news/press-rel… #cancer #CancerResearch